SCHEMBL6394396

SCHEMBL6394396

CCOc1ccccc1CN(C(=O)CCc1ccc(OC)cc1)C1CCNCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 4/20 0.50
SLC6A2 P23975 6/20 0.48
SLC6A4 P31645 6/20 0.48
SLC6A3 Q01959 5/20 0.48
CYP2D6 P10635 1/20 0.48
KCNH2 Q12809 2/20 0.48
RPLP1 P05386 2/20 0.47
RPLP0 P05388 2/20 0.47
RPS17 P08708 2/20 0.47
RPSA P08865 2/20 0.47
RPS2 P15880 2/20 0.47
RPL35A P18077 2/20 0.47
RPL7 P18124 2/20 0.47
RPL17 P18621 2/20 0.47
RPS4Y1 P22090 2/20 0.47
RPS3 P23396 2/20 0.47
RPS12 P25398 2/20 0.47
RPL13 P26373 2/20 0.47
RPL10 P27635 2/20 0.47
RPL12 P30050 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4919198 0.93 TACR1 (0.52) TACR1SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL340465 0.83 SLC6A2 (0.51) TACR1SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL4912849 0.81 ALOX5 (0.52) TACR1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL339372 0.76 TACR1 (0.57) TACR1SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL4210498 0.75 MBTPS1 (0.59) SLC6A2SLC6A4SLC6A3KCNH2MBTPS1
SCHEMBL339220 0.73 TACR1 (0.61) TACR1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL341939 0.72 ALOX5 (0.60) SLC6A2SLC6A4SLC6A3KCNH2OPRM1
SCHEMBL339704 0.71 TACR1 (0.55) TACR1SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL340969 0.71 ALOX5 (0.55) SLC6A2SLC6A4SLC6A3KCNH2RPLP1
SCHEMBL28770699 0.71 TACR1 (0.57) TACR1SLC6A2SLC6A4SLC6A3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014757-A1 Azacyclic compounds ANDERSSON CARL-MAGNUS A (DK) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014757-A1 Azacyclic compounds HTR6, TPMT, HNMT TACR1 124/4885SLC6A2 48/4885SLC6A4 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.